Nalu Bio

Nalu Bio

Signal active

Organization

Contact Information

Overview

Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700x less land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis.

About

Industries

Biotechnology, Health Care, Chemical, Alternative Protein

Founded

2019

Employees

11-50

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Nalu Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Chemical, Alternative Protein sector. The company focuses on Biotechnology and has secured $784.0M in funding across 64 round(s). With a team of 11-50 employees, Nalu Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Nalu Bio, raised $250.0K. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Caitlyn Krebs

Caitlyn Krebs

Co-Founder and CEO

Funding Rounds

Funding rounds

4

Investors

1

Lead Investors

0

Total Funding Amount

$12.3M

Details

4

Nalu Bio has raised a total of $12.3M in funding over 4 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Seed
2021Seed
2023Early Stage Venture12.0M
2022Seed250.0K

Investors

Nalu Bio is funded by 20 investors.

Investor NameLead InvestorFunding RoundPartners
Portfolia-FUNDING ROUND - Portfolia12.0M
Nalu Bio-FUNDING ROUND - Nalu Bio12.0M
Flybridge-FUNDING ROUND - Flybridge12.0M
Nalu Bio-FUNDING ROUND - Nalu Bio250.0K

Recent Activity

There is no recent news or activity for this profile.